Company intelligence / Profile preview

Xintrum Pharmaceuticals, Ltd.

Not explicitly stated; likely Lianyungang or another major city within Jiangsu province., Jiangsu Sheng, Chinaen.xintrum.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Xintrum Pharmaceuticals is a biomedical company focused on R&D and manufacturing of new drugs. Its pipeline includes early clinical-stage assets targeting obesity and neurotrophic keratitis using antibody fusion proteins and recombinant growth factors. As of March 2025, its lead programs are in Phase 1 clinical trials.

Therapeutic areas: EndocrinologyOphthalmology
Modalities: Antibody fusion proteinsGrowth factorsRecombinant proteins
Industry: Biotech

Beyond the preview

Go deeper on Xintrum Pharmaceuticals, Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xintrum Pharmaceuticals, Ltd..

Explore the full profile